Curated News
By: NewsRamp Editorial Staff
April 15, 2026
MindBio Appoints Market Maker to Boost Trading for AI Voice Intoxication Tech
TLDR
- MindBio Therapeutics appoints Venture Liquidity Providers to enhance stock liquidity and investor appeal through market-making services.
- MindBio will pay $5,000 monthly for 12 months to VLP, which operates through W.D. Latimer Co. Ltd. under CSE policies to maintain orderly trading.
- MindBio's AI voice analytics for intoxication detection aims to improve workplace safety in industries like mining and aviation.
- MindBio uses AI with 50 million data points to detect alcohol intoxication just from voice analysis, developing Edge-AI kiosks for enterprise use.
Impact - Why it Matters
This news matters because it highlights a biotechnology company's strategic move to stabilize its financial market presence while advancing innovative AI technology for intoxication detection. MindBio's voice analytics platform could transform safety protocols in critical industries like mining, aviation, and law enforcement by providing a non-invasive, accurate method to detect drug and alcohol impairment. For investors, the market-making services may enhance stock liquidity and reduce volatility, making the company more attractive. More broadly, this development reflects the growing role of AI in healthcare and safety, with potential to reduce accidents, improve workplace compliance, and save lives, positioning MindBio at the forefront of a niche but impactful sector in the life sciences industry.
Summary
MindBio Therapeutics Corp., a biotechnology company trading on the CSE, Frankfurt, and OTCQB exchanges, has taken a significant step to enhance its market presence by appointing Venture Liquidity Providers (VLP) to provide market-making services for its common shares. This strategic move, conducted through W.D. Latimer Co. Ltd. in compliance with Canadian Securities Exchange policies, involves a $5,000 monthly payment over a 12-month term and aims to maintain an orderly trading market. The announcement was disseminated through the specialized communications platform BioMedWire, which is part of the broader Dynamic Brand Portfolio managed by IBN, highlighting the company's focus on reaching investors and the public in the biotechnology sector.
At its core, MindBio is commercializing innovative AI-driven voice analytics technology designed to detect drug and alcohol intoxication with remarkable accuracy using over 50 million data points. The company is developing an enterprise platform that includes Edge-AI kiosks integrating bespoke hardware and software for use in high-stakes environments such as the mining industry, aviation, construction, and law enforcement. This technology represents a cutting-edge approach to safety and compliance, leveraging the human voice as a non-invasive tool for intoxication detection, which could revolutionize workplace safety protocols and regulatory enforcement.
The news release emphasizes the company's commitment to transparency and investor engagement, with additional information available in its newsroom and through the BioMedWire platform, which offers enhanced press release distribution and social media outreach via IBN. By partnering with VLP for market-making services, MindBio aims to stabilize its stock trading and attract broader investor interest, supporting its mission to advance AI prediction technologies in the life sciences. This development underscores the growing intersection of biotechnology and artificial intelligence, positioning MindBio as a key player in the emerging field of voice-based intoxication detection, with potential applications that could impact public health and safety on a global scale.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, MindBio Appoints Market Maker to Boost Trading for AI Voice Intoxication Tech
